News
Rett syndrome hits hard and early, but with Neuren’s Daybue and Neurotech’s cannabis-based NTI164 building steam, the fight ...
Australia’s S&P/ASX 200 rose 2.36% in July, posting gains of almost 9% so far for CY25 with health care rebounding 9% for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback